In a recent review published by Prevention, the Brooks Adrenaline GTS 26 is described as a stability-focused athletic shoe that balances comfort and support.
The latest iteration of the long-standing model features a nitrogen-infused DNA LOFT v3 foam midsole and the company’s signature GuideRails Technology. Brooks markets the sneaker as its “most trusted support shoe,” and it is a long-standing favorite of actor Jennifer Garner.
According to the review, the GuideRails system works to control excess motion at the foot and knee. Anne Sharkey, a board-certified podiatrist and founder of Solely Podiatry, noted the following regarding the technology:
“Which helps control excess motion at the foot and knee,” said Anne Sharkey, D.P.M., a board-certified podiatrist and founder of Solely Podiatry in Austin. “This makes this shoe an excellent option for walkers and runners who need stability while maintaining a smooth, comfortable ride.”
The shoe’s design updates focus on the upper, replacing the bulkier tongue of the previous version with a flat-knit version intended to contour to the foot. The shoe also includes a refreshed padded collar and a heel loop for improved entry. The midsole construction utilizes large-cell foam designed to compress with each step to provide softness without sacrificing structural integrity.
The sneaker is available in sizes 5 through 13, with options for extra narrow, narrow, medium, and wide widths, and comes in six colorways. It weighs 9.6 ounces and features a 10mm heel drop.
Senior Reviews Editor Charlotte Finigan has evaluated the last two versions of the model, awarding them high marks for providing comfort, support, and protection against plantar fasciitis flare-ups. The shoe also holds the top position in a podiatrist-recommended roundup of stability footwear.
Brooks, which was founded in 1914, originally manufactured footwear for a broad range of sports, including bathing shoes and ballet slippers. The company underwent a significant strategic shift in 2001, when it cut its product line by more than 50% to focus exclusively on the running market. This pivot toward performance technology proved successful, as the brand became the top-selling name in the specialty running shoe market by 2011.
The company also holds a history of material innovation within the industry, having been the first to utilize EVA, an air-infused foam, in its performance running shoes in 1975. Today, the Seattle-based organization operates as a subsidiary of Berkshire Hathaway and distributes its products in 60 countries worldwide.

Testing conducted over three weeks involved daily walking in New York City, where the sneaker was found to provide a secure fit. As Alastair reported, the model maintains a 10mm drop and a stack height of 36mm at the heel and 26mm at the forefoot. The shoe remains a stability option that does not utilize a medial post, instead relying on raised sidewalls to provide support only when the foot strays from its natural path.
The reengineered DNA LOFT v3 foam is intended to provide a smoother transition and increased energy return at toe-off. While the shoe maintains a ride similar to the previous GTS 25, the updates to the upper, including the flat-knit tongue and heel loop, are designed to refine the fit for heel strikers and those needing stability during long-distance efforts or daily walks.